Bullboard Post History

by Trogarzon

Order by:

T.TH	RE:RE:RE:RE:RE:RE:RE:RE:RE:The full article published yesterday So what's the next milestone now. There is value creation scheduled... February 26, 2024
T.TH	RE:RE:RE:RE:RE:RE:RE:The full article published yesterday They have 5M and until the end of H1 to make the case for their platform in... February 26, 2024
T.TH	RE:Weight Loss drugs could boost GDP - Goldman Sacks What does that accomplish for us. We have no patent on F4 and F8 ain... February 23, 2024
T.TH	RE:RE:RE:RE:RE:RE:RE:RE:Obesity drugs Next time I see anyone overthere buy 100k+ of shares I'll beleive all is... February 22, 2024
T.TH	RE:RE:RE:RE:RE:RE:RE:Obesity drugs They spent over 400M since 1993 in R&D. They were above 1B market... February 22, 2024
T.TH	RE:RE:RE:RE:Obesity drugs There is no more patent on Egrifta. Any market more interesting than... February 22, 2024
T.TH	red in a sea of green But Paul said vaue creation later this year... working on it very hard. ... February 22, 2024
T.TH	RE:RE:At least another year of waiting... This guy should go or be made to go. February 21, 2024
T.TH	RE:RE:At least another year of waiting... His tone was downbeat, the conclusion was read blatantly. Not shure why he... February 21, 2024
T.TH	RE:At least another year of waiting... Did mention one again strong interest for onco (Novartis is shopping PDCs... February 21, 2024
T.TH	Conf. call. Paul sounds monotone and drabe.... February 21, 2024
T.TH	RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance There is a 40M tranche coming du in June of 2024 and the remaining 20 in 2025... February 21, 2024
T.TH	RE:RE:RE:RE:New Press Release - Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance Once they pay that back how do they maintain the 15M minimum and finance... February 21, 2024
T.TH	RE:RE:RE:New Press Release - Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance They need to payback 40M come June to shylockoton. They had 40M back in... February 21, 2024
T.TH	RE:RE:New Press Release - Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance F8 CRL was costly.. like 3-4M costly... February 21, 2024
T.TH	RE:RE:RE:RE:RE:RE:The full article published yesterday When they start putting money where their mouth is we may have a sign of... February 20, 2024
T.TH	RE:RE:It has been 5 years almost to the Day Either Sort1 pans out and we'll get our money back with interest or it... February 20, 2024
T.TH	RE:It has been 5 years almost to the Day Can't even cover the initial cost atm. Anyone seen Beliveau lately.... February 20, 2024
T.TH	RE:RE:Tomorrow Maybe they sell the HIV business for something like 200M, pay off the shylock... February 20, 2024
T.TH	Tomorrow Tomorow is Q4 + Year End. The market is not anticipating much of upside... February 20, 2024

Become a member today, It's free!

Bullboard Post History

by Trogarzon

RE:RE:RE:RE:RE:RE:RE:RE:RE:The full article published yesterday

RE:RE:RE:RE:RE:RE:RE:The full article published yesterday

RE:Weight Loss drugs could boost GDP - Goldman Sacks

RE:RE:RE:RE:RE:RE:RE:RE:Obesity drugs

RE:RE:RE:RE:RE:RE:RE:Obesity drugs

RE:RE:RE:RE:Obesity drugs

red in a sea of green

RE:RE:At least another year of waiting...

RE:RE:At least another year of waiting...

RE:At least another year of waiting...

Conf. call.

RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

RE:RE:RE:RE:New Press Release - Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

RE:RE:RE:New Press Release - Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

RE:RE:New Press Release - Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

RE:RE:RE:RE:RE:RE:The full article published yesterday

RE:RE:It has been 5 years almost to the Day

RE:It has been 5 years almost to the Day

RE:RE:Tomorrow

Tomorrow

Featured Company

Biosenta Inc. C.ZRO

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by Trogarzon

Featured Company